AIM IMMUNOTECH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.38 USD | +7.65% |
|
+8.57% | -13.62% |
| May. 16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
| May. 15 | AIM ImmunoTech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar AIM ImmunoTech Inc.
270f9bdda5e8e14c27cbba4ef97afa7d._9AzX_plQilHvEyjNDPN1gG8miZS896PTO01bnf7Ha4.s4heC8gIK0s0yR7rZHq_ozXv6x8gl63iGL5lDSGfepeNv0ZyyAoWbTbZCQ~b8d37cd2b2c083d66ed096c1dde6eeb4
Upcoming events on AIM ImmunoTech Inc.
Past events on AIM ImmunoTech Inc.
| 2024-05-22 03:40 pm | Webull Corporate Connect Biotech Investment Conference |
| 2024-05-21 03:20 pm | Alliance Global Partners Healthcare Showcase |
| 2024-05-16 08:30 am | Q1 2024 Earnings Call |
| 2024-05-16 07:30 am | Q1 2024 Earnings Release |
| 2024-04-03 01:35 pm | MedInvest Biotech & Pharma Investor Conference |
| 2024-04-02 08:30 am | Q4 2023 Earnings Call |
| 2024-04-02 07:30 am | Q4 2023 Earnings Release |
| 2024-03-20 12:00 pm | AIM ImmunoTech Virtual Investor Lunch Break Conference |
| 2024-01-04 | Annual General Meeting - Proxy Fight for Board Control |
| 2023-12-05 12:00 am | Noble Capital Markets Emerging Growth Equity Conference |
| 2023-12-01 11:00 am | Annual General Meeting - Proxy Fight for Board Control |
| 2023-11-15 08:30 am | Q3 2023 Earnings Call |
| 2023-11-15 07:30 am | Q3 2023 Earnings Release |
| 2023-09-21 | Marie Sklodowska-Curie on Cancer Research and Care Symposium |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-15 08:30 am | Q2 2023 Earnings Call |
| 2023-08-15 06:45 am | Q2 2023 Earnings Release |
| 2023-07-12 11:00 am | Virtual Investor Summer Spotlight Conference |
| 2023-06-21 12:00 pm | Maxim Group Virtual Healthcare Conference |
| 2023-05-16 08:30 am | Q1 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,14 0,48 -71.09% | 0,16 0,19 -14.66% | 0,14 0,12 11.88% | 0,14 0,24 -41.17% | 0,20 0,16 28.66% | 0,17 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -12,4 -11,9 -4.73% | -15,0 -13,0 -15.83% | -17,1 -15,9 -7.09% | -19,9 -20,0 0.21% | -31,9 -24,3 -31.42% | -23,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,53 -11,0 13.11% | -14,4 -13,6 -5.53% | -19,1 -17,5 -9.2% | -19,4 -20,9 7.06% | -29,0 -21,6 -34.38% | -22,4 |
|
Net income Million USD | Released Forecast Spread | -9,53 -11,0 13.11% | -14,4 -13,4 -7.52% | -19,1 -17,9 -7% | -19,4 -20,3 4.28% | -29,0 -22,5 -28.57% | -22,4 |
|
EPS USD | Released Forecast Spread | -2,62 -3,73 29.66% | -0,45 -0,43 -5.47% | -0,40 -0,38 -6.19% | -0,40 -0,44 8.05% | -0,60 -0,45 -33.33% | -0,44 |
| Announcement Date | 30/03/20 | 31/03/21 | 31/03/22 | 31/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,03 0,10 -67% | 0,03 0,14 -78.21% | 0,02 0,02 40% | 0,06 0,18 -69.51% | 0,05 0,00 - | 0,04 0,02 82.61% | 0,05 0,02 91.67% | 0,07 0,04 78.08% | 0,04 0,00 - | 0,00 | 0,00 | 0,10 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,15 -4,50 29.96% | -4,70 -3,60 -30.26% | -6,52 -4,55 -43.21% | -5,56 -5,62 1.12% | -4,30 -5,50 21.91% | -5,46 -5,13 -6.42% | -8,16 -5,58 -46.26% | -14,0 -6,37 -119.79% | -5,73 -5,50 -4.25% | -6,11 | -5,98 | -6,11 | -5,60 | -5,60 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,82 -4,50 15.11% | -4,85 -3,62 -33.95% | -6,39 -4,92 -29.78% | -4,39 -5,89 25.52% | -3,66 -5,50 33.44% | -4,91 -5,34 8.06% | -7,82 -5,76 -35.74% | -12,6 -5,53 -127.5% | -5,82 -5,50 -5.76% | -5,50 | -5,50 | -5,50 | -5,60 | -5,60 |
|
Net income Million USD | Released Forecast Spread | -3,82 -4,50 15.11% | -4,85 -3,62 -33.95% | -6,39 -4,92 -29.78% | -4,39 -5,89 25.52% | -3,66 -5,50 33.44% | -4,91 -5,34 8.06% | -7,82 -5,76 -35.74% | -12,6 -5,53 -127.5% | -5,82 -5,50 -5.76% | -5,50 | -5,50 | -5,50 | -5,60 | -5,60 |
|
EPS USD | Released Forecast Spread | -0,08 -0,09 11.11% | -0,10 -0,08 -33.33% | -0,13 -0,10 -30% | -0,09 -0,13 28% | -0,08 -0,11 27.27% | -0,10 -0,11 9.09% | -0,16 -0,12 -39.13% | -0,26 -0,09 -188.89% | -0,12 -0,11 -9.09% | -0,11 | -0,11 | -0,11 | -0,11 | -0,11 |
| Announcement Date | 13/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 01/04/24 | 15/05/24 | - | - | - | - | - |
More events
Past sector events for AIM ImmunoTech Inc.
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AIM Stock
- Calendar AIM ImmunoTech Inc.
